Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer
Status:
Completed
Trial end date:
2015-11-18
Target enrollment:
Participant gender:
Summary
This research is being done to see if an investigational radioactive drug called 18F-DCFBC
can help us find cancer that has spread (metastatic disease) from its original site in people
who have cancer in their prostate to other parts of their body.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins